Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma

Since completion of the Trastuzumab for Gastric Cancer study, trastuzumab with doublet chemotherapy (a fluoropyrimidine and a platinum) has been the gold-standard first-line therapy for patients with locally advanced unresectable or metastatic human epidermal growth factor receptor 2-positive (HER2+...

Descripción completa

Detalles Bibliográficos
Autores principales: Catenacci, D.V.T., Chung, H.C., Shen, L., Moehler, M., Yoon, H.H., Rosales, M.K., Kang, Y.-K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728435/
https://www.ncbi.nlm.nih.gov/pubmed/34973512
http://dx.doi.org/10.1016/j.esmoop.2021.100360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728435/
https://www.ncbi.nlm.nih.gov/pubmed/34973512
http://dx.doi.org/10.1016/j.esmoop.2021.100360

Ejemplares similares